1[1]Levey AS,Coresh J,Balk E,et al.National kidney foundation practice guidelines for chronic kidney disease:evaluation,clas sification,and stratification[J].Ann Intern Med,2003,139(2):137-147.
2陈文彬.诊断学[M].北京:人民卫生出版社,2002.167-168.
3[3]Feldt-Rasmussen B,Borch-Johnsen K,Deckert T,et al.Microalbuminuria:an important diagnostic tool[J].J Diabetes Complications,1994,8(3):137-145.
4[4]Bigazzi R,Bianchi S,Baldarid D,et al.Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension[J].J Hypertens,1998,16(9):1325-1333.
5[5]Crook ED,Flack JM,Salem M,et al.Primary renal disease as a cardiovascular risk factor[J].Am J Med Sci,2002,324(3):138-145.
6[6]Peter Andrews P Renal dysfunction as a marker of Increased vascular risk[J].Br.J Diabetes Vasc Dis,2004,4(3):152-155.
7[7]Mann JFE,Gerstein HC,Pogue J,et al.Renal insufficiency as a pridictor of cardiovascular outcomes and the impact of ramipril:the HOPE randomized trial[J].Ann Intern Med,2001,134(8):629-636.
8[8]Matthew F,YuYun,Kay-Tee Khan,et al.A prospective study of microalbuminuria and incident coronary heart disease and its prognostic significance in a British popalation[J].American Journal of Epidemiology,2004,159(3):284-293.
3Locatelli F, Pozzoni P, Tentori F, et al. Epidemiology of cardiovascular risk in patients with chronic kidney disease. Nephrol Dial Transplant, 2003,18 Suppl 7:2-9.
4Muntner P, He J, Hamm L, et al. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol, 2002,13:745-753.
5Manjunath G, Tighiouart H, Ibrahim H, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol, 2003,41:47-55.
6Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int, 1995,47:186-192.
7Sarnak MJ, Levey AS, Schoolwerth AC,et al. Kidney disease as a risk factor for development of cardiovascular disease. A statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation, 2003,108:2154-2169.
8Foley RN, Herzog CA, Collins AJ. Smoking and cardiovascular outcomes in dialysis patients: the United States Renal Data System Wave 2 Study. Kidney Int, 2003,63:1462-1467.
9Wong JS, Rort FK, Hulbert-Shearon TE, et al. Survival advantage in Asian American end-stage renal disease patients. Kidney Int, 1999,55:2515-2523.
10Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis, 1998,32:s112-s119.
2Fischer M,Baessler A,Hense HW,et al.Prevalence of left ventficular diastolic dysfunction in the community.Results from a Doppler cchocardiographic-based survey of a population sample[J].Eur Heart J,2003,24(4):320-328.
3Volpe M,Pagannone E,Tocci G,et al.Hypertension and heart failure:role of neurohormonal mechanisms[J].Clin Exp Hypertens,2004,26(7-8):603-610.
